Iguana Healthcare Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Iguana Healthcare Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-50,000	Closed	-$1.13M	–	89
2015 Q1	$1.13M	Sell	50,000 -25,000	-33%	-$579K	0.47%	51
2014 Q4	$1.51M	Buy	75,000 +25,000	+50%	+$453K	0.73%	45
2014 Q3	$913K	Hold	50,000	–	–	0.49%	50
2014 Q2	$674K	Sell	50,000 -40,000	-44%	-$545K	0.31%	60
2014 Q1	$1.48M	Buy	+90,000	New	+$1.56M	0.68%	44

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Iguana Healthcare Management's FLXN Position: Q2 2015 in Review

Iguana Healthcare Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2015, closing a stake of 50,000 shares — an estimated $1.13M sold.

Iguana Healthcare Management first reported a position in FLXN in Q1 2014 and held it in 5 quarters. The position peaked at $1.51M in Q4 2014. 61 funds tracked by Wall St. Rank hold FLXN as of Q2 2015.

Iguana Healthcare Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
Iguana Healthcare Management sold 50,000 Flexion Therapeutics, Inc. shares in Q2 2015, an estimated $1.13M.
Iguana Healthcare Management first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 5 quarters.
Iguana Healthcare Management's Flexion Therapeutics, Inc. position peaked at $1.51M in Q4 2014.
61 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2015.

Based on Iguana Healthcare Management's 13F filing for Q2 2015, filed 14 Aug 2015.